HiroPharmaConsulting (R) Granted Patent for AI-enabled Reliability Assurance Method for Pharmacovigilance Systems
OSAKA, Japan, Dec. 4, 2025 /PRNewswire/ -- HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Validation (CSV) methodology designed to ensure the...
NX Group Participates in Shanghai's 8th China International Import Expo (CIIE)
TOKYO, Dec. 3, 2025 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. took part in the six-day 8th China International Import Expo (CIIE) held in Shanghai, China from Wednesday, November 5 to Monday, November 10. Logo:...
Asurion to Acquire Domestic & General, Establishing a Global Leader in Technology and Appliance Care Committed to Excellence in Customer Service
The combined company will accelerate Asurion's vision to become CTO of the home, by delivering seamless, intelligent care for every connected device and appliance in the home and making technology simpler, more reliable, and more sustainable for...
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Zeekr Group Announces November 2025 Delivery Update
HANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for November 2025. In...
NX China Receives China's Highest Rating of Class 5A Logistics Enterprise
- Becoming 1st Japanese-affiliated Logistics Company to Receive This Top Rating - TOKYO, Dec. 1, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., was recognized by the...
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma
CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic...
Xinhua Silk Road: Chinese tin industry giant to expand global presence with innovative endeavors
BEIJING, Nov. 28, 2025 /PRNewswire/ -- Southwest China-situated refined tin producer Yunnan Tin Group (Holding) Co., Ltd. is revving up its paces to delve deeper into global tin market with innovation-led growth now. Photo shows a panoramic view of...
swop 2025: Shanghai World of Packaging Grandly Held in November, Marking Its 10th Anniversary
SHANGHAI, Nov. 25, 2025 /PRNewswire/ -- The Shanghai World of Packaging (swop), co-organized by Messe Düsseldorf (Shanghai) Co., Ltd. and Adsale Exhibition Services Ltd., took place from November 25–27, 2025, at SNIEC (Shanghai New International...
Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint
CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study...